卡尔莫杜林2的表达与乳腺癌的预后不佳有关
Ju Yang1, Shuixian Li2, Jigang Wang3
1Department of Pathology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Pathology, research and practice
|May 16, 2024
概括
在乳腺癌 (BRCA) 中,卡尔摩杜林2 (CALM2) 的含量升高,预测存活率较低. 准CALM2可能为BRCA患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 卡尔莫杜林2 (CALM2) 是一种与各种癌症有关的结合蛋白.
- 它在乳腺癌 (BRCA) 病原发生中的作用需要进一步研究.
研究的目的:
- 为了研究BRCA中的CALM2表达.
- 分析其与预后,临床病理特征和潜在治疗向的关联.
主要方法:
- 对CALM2表达和临床相关性的生物信息学分析.
- 在BRCA组织和细胞系中用于CALM2验证的西部涂抹和免疫组织化学.
- 功能性测试 (Transwell) 评估CALM2在BRCA细胞迁移和入侵中的作用.
主要成果:
- 在BRCA组织中,CALM2的表达显著上调.
- 升高的CALM2水平与整体存活率差和无病存活率差相关.
- 过度表达CALM2与淋巴结转移,TP53突变和更年期状态有关,特别是在三阴性乳腺癌 (TNBC) 中.
- 在体外研究表明,CALM2沉默抑制BRCA细胞迁移和入侵.
结论:
- 在BRCA中,CALM2过度表达,并与不良的患者预后有关.
- CALM2代表了BRCA的潜在预后生物标志物和治疗点.
相关概念视频
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


